Exosomes · Lesson 12 of 18 · 3 min

Exosomes in aesthetics: skin, hair and wound healing

What clinicians should know about exosomes in aesthetic medicine: the rationale for skin, hair and scars, the limits, and the regulatory position.

A gloved hand pipetting into small vials on a lab bench

Key takeaways.

  • Aesthetics is one of the fastest growing application areas for exosomes, driven by patient demand.
  • The rationale targets the epidermis and dermis, where most visible skin aging originates.
  • Exosomes are not expected to address facial bone resorption or fat atrophy.
  • Hair, wound healing, scars and body skin laxity are also under study.
  • Exosomes are usually combined with established modalities, most often microneedling.
  • Exosomes are not FDA-approved for any therapeutic use, including aesthetic use.

Why aesthetics has adopted exosomes quickly

Aesthetic medicine is one of the most rapidly growing application areas for exosomes. Skin is easy to reach, patient demand for non-surgical options is high, and the proposed mechanisms overlap with those studied in wound healing.

The course material is direct that commercial pressure in this field can encourage overpromising. Clinicians are expected to keep scientific rigor and set realistic expectations.

Skin aging and the rationale

Skin aging has two components. Intrinsic aging follows genetics and time. Extrinsic aging comes from the environment, especially ultraviolet radiation.

Facial aging involves the epidermis, dermis, fat, muscle and bone. The rationale for exosomes is limited to the epidermis and the dermis, the connective tissue layer that determines firmness and elasticity. Exosomes are not expected to address bone resorption or fat atrophy.

Hair, wounds and scars

In hair, research centers on androgenetic alopecia, also called pattern hair loss, and on whether exosomes influence hair follicle function. The course material notes that this field has a history of disappointing options, so claims deserve scrutiny.

Wound healing runs through overlapping phases: hemostasis and inflammation, proliferation, and remodeling. Exosomes are being studied for chronic wounds and scarring, where that sequence goes wrong. Body skin laxity is described as an emerging application.

How exosomes are used alongside other treatments

Exosomes are relative newcomers and are usually combined with established modalities. Microneedling is the most common pairing, because it temporarily opens the skin barrier.

None of this changes the regulatory position. Exosome therapies are not FDA-approved for therapeutic use, and aesthetic evidence is still limited.

Educational content for healthcare professionals. Not a treatment recommendation. Exosome therapies are not FDA-approved for therapeutic use.

Exosomes: 0 of 18 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Combination approaches and how they are sequenced
  • Evidence review for facial and hair studies
  • Regulatory limits on aesthetic use and claims
  • Setting patient expectations

Common questions.

Are exosomes FDA-approved for skin rejuvenation or hair loss?
No. Exosome therapies are not FDA-approved for any therapeutic use, including skin and hair applications.
Why are exosomes combined with microneedling?
Microneedling creates microscopic channels through the outer skin layers, which temporarily compromises the skin barrier. This is the stated rationale for pairing the two.
Can exosomes replace fillers or surgery?
The course material does not support that. Exosomes are not expected to address volume loss from fat atrophy or bone resorption, and evidence for aesthetic outcomes is limited.

Sources

  • Shabbir, A., et al. (2015). Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts. Stem Cells and Development, 24(14), 1635-1647.
  • Kwon, H. H., et al. (2020). Efficacy of exosome-derived growth factors in skin rejuvenation. Journal of Dermatological Treatment, 31(7), 704-710.
  • Cho, B. S., et al. (2021). Human adipose tissue-derived mesenchymal stem cells-derived exosomes promote hair regrowth. Stem Cells Translational Medicine, 10(9), 1205-1213.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.